Fortrea Holdings Inc. (FTRE) 宣布对其高管团队进行重要扩充，引入两位资深专业人士。公司正式任命欧仁·科恩博士担任首席医疗官一职，他将负责领导公司的全球医疗事务战略。与此同时，斯科特·达夫被任命为临床药理学服务部门总裁，他将主导该核心业务部门的运营与发展。此次高层人事变动旨在加强公司在合同研究组织领域的领导地位，并推动其科学和临床服务的卓越发展。
Fortrea Holdings Inc. (FTRE) 宣布对其高管团队进行重要扩充，引入两位资深专业人士。公司正式任命欧仁·科恩博士担任首席医疗官一职，他将负责领导公司的全球医疗事务战略。与此同时，斯科特·达夫被任命为临床药理学服务部门总裁，他将主导该核心业务部门的运营与发展。此次高层人事变动旨在加强公司在合同研究组织领域的领导地位，并推动其科学和临床服务的卓越发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.